Although the improvement with trastuzumab alone did not reach statistical significance, a trend toward overall survival benefit was observed (Fig. 3 B).
← all excerpts
Development of a prognostic risk stratification model for HER2-positive breast cancer brain metastasis and its implications in guiding treatment decisions.
1
—
—